RVPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
RETRACTABLE TECHNOLOGIES INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.58+0.00 (+0.33%)
Close on Oct 19, 2026
- Market cap
- $17.30M
- P/E (TTM)
- –
- Dividend yield
- –
RETRACTABLE TECHNOLOGIES INC revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Single reportable segment | $38.27M | $33.05M | $43.60M | – | – | – | – | – | – | – | 100.0% | +15.8% |
| Sales to U.S. government | – | – | – | $15.73M | $113.66M | $31.63M | – | – | – | – | – | – |
| Other international sales | – | – | $2.91M | $13.47M | $6.27M | $1.17M | – | – | – | – | – | – |
| North and South America sales (excluding U.S.) | – | – | $6.09M | $29.13M | $14.56M | $6.89M | – | – | – | – | – | – |
| U.S. sales (excluding U.S. government) | – | – | $34.60M | $36.49M | $53.89M | $42.17M | – | – | – | – | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Syringes | $24.91M | $22.63M | $34.16M | $86.74M | $176.33M | $68.73M | $35.64M | $28.27M | $31.01M | $27.74M | 65.1% | +10.1% |
| EasyPoint Needles | $11.94M | $8.95M | $7.25M | $4.67M | $9.64M | $9.63M | $2.98M | $3.41M | $2.07M | $1.34M | 31.2% | +33.5% |
| Blood Collection Products | $1.37M | $1.43M | $1.93M | $2.95M | $2.25M | $2.36M | $2.72M | $1.42M | $1.15M | $590.85K | 3.6% | -3.9% |
| Other Products | $43.63K | $45.85K | $266.27K | $451.95K | $167.56K | $1.14M | $464.05K | $172.41K | $272.34K | $159.33K | 0.1% | -4.9% |
| Licensing fees | $0 | $189.00K | $778.00K | $0 | – | – | – | – | – | – | 0.0% | -100.0% |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | – | – | – | – | $53.89M | $42.17M | $31.90M | $28.65M | $27.02M | $26.31M | – | – |
| North and South America (excluding U.S.) | – | – | – | – | – | $6.89M | $8.25M | $3.60M | $6.38M | $2.74M | – | – |
| Other international sales | – | – | – | – | $6.27M | $1.17M | $1.65M | $1.03M | $1.10M | $776.87K | – | – |
| North and South America (excluding U.S) | – | – | – | – | $14.56M | $6.89M | $8.25M | – | – | – | – | – |
| Sales to U.S. government | – | – | – | – | $113.66M | $31.63M | – | – | – | – | – | – |
From the segment and revenue-disaggregation notes of Retractable Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.